サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1564053

犬幹細胞治療の世界市場

Canine Stem Cell Therapy

出版日
ページ情報
英文 197 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.18円
犬幹細胞治療の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

犬幹細胞治療の世界市場は2030年までに2億5,380万米ドルに達する見込み

2023年に2億10万米ドルと推定された犬幹細胞治療の世界市場は、2030年には2億5,380万米ドルに達し、分析期間2023-2030年のCAGRは3.5%で成長すると予測されます。本レポートで分析したセグメントの一つである同種幹細胞は、CAGR 3.9%を記録し、分析期間終了時には1億7,480万米ドルに達すると予測されます。自己幹細胞セグメントの成長率は、分析期間中CAGR 2.5%と推定されます。

米国市場は5,290万米ドルと推定される一方、中国はCAGR 3.3％で成長すると予測

米国の犬幹細胞治療市場は、2023年に5,290万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4,060万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは3.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と2.8％と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の犬幹細胞治療市場- 主要動向と促進要因のまとめ

犬幹細胞治療が動物医療で人気を集める理由とは？

犬幹細胞治療は、動物医療における画期的な治療法として急速に普及しており、特に犬の変性疾患、怪我、免疫疾患など、かつては管理が困難であった症状に希望をもたらしています。幹細胞、特に犬自身の脂肪組織由来の幹細胞（脂肪由来幹細胞）は、損傷した組織を再生し、炎症を抑え、全体的な治癒を促進するユニークな能力を持っています。この治療法は、変形性関節症、股関節形成不全、靭帯損傷などの筋骨格系疾患の治療に最も一般的に用いられています。これらの疾患に対する従来の治療法、例えば非ステロイド性抗炎症薬（NSAIDs）、理学療法、あるいは外科的手術は、一時的な緩和をもたらすが、副作用や合併症のリスクを伴うことが多いです。対照的に、幹細胞療法は侵襲性の低い解決策を提供し、より長期の効果が期待できます。幹細胞療法は、体の自然治癒プロセスを利用することで、犬の運動能力や生活の質に影響を与える症状を治療する、より総合的なアプローチとなります。より多くの獣医師や飼い主がその利点を認識するにつれて、犬幹細胞治療の需要は高まっており、動物医療における高度な再生療法への幅広いシフトを反映しています。

技術はどのように犬幹細胞治療を進化させているのか？

犬幹細胞治療の成功とその広がりは、バイオテクノロジーと再生医療の急速な進歩と密接に結びついています。過去10年の間に、幹細胞の加工や投与方法において大きな進歩があり、獣医師と飼い主の両方にとって、これらの治療の安全性、有効性、利便性が向上しています。脂肪由来幹細胞を採取し、処理する方法が改良され、幹細胞の抽出、精製、拡大が専門の研究室でより迅速かつ正確に行えるようになったことも大きな進歩のひとつです。幹細胞の質と生存率が治療の可能性に直接影響するためです。加えて、特に患者から幹細胞を採取することが困難な場合に、ドナーとなる動物由来の同種幹細胞を使用することも新たな動向となっています。このアプローチは治療の幅を広げ、自家幹細胞採取が困難な基礎疾患を持つ犬にも解決策を提供します。採取した幹細胞を長期保存し、何度も手術することなく将来の治療に再利用することを可能にする凍結保存技術も大きな進歩です。このような技術革新に加え、MRIや超音波のような撮像技術を用いることで、幹細胞注入の標的を正確に定めることができるようになり、幹細胞治療はより身近なものになっただけでなく、複雑で慢性的な疾患に対してより効果的なものとなりました。

どのような動向と課題が犬幹細胞治療市場を形成しているのか？

犬幹細胞治療市場の急成長と進化を形成している主要な動向はいくつかあるが、その大きな促進要因となっているのは、ペットのための非侵襲的な再生治療に対する需要の高まりです。ペットの飼い主が高度な獣医学的治療の選択肢について知識を深めるにつれ、従来の治療と比較してより少ない副作用でより良い結果をもたらすことができる治療法に対する嗜好が高まっています。この動向は、ペットケア業界におけるホリスティックで統合的な治療への幅広い動きと一致しており、そこでは、単に症状を管理するのではなく、全体的な健康を促進し、症状の根本原因に対処することに重点が置かれています。さらに、変形性関節症などの退行性関節疾患の治療に幹細胞治療が有効であることを裏付ける研究や臨床的エビデンスの広がりは、獣医師の間で幹細胞治療の信頼性を高め、その採用をさらに後押ししています。しかし、こうした前向きな動向にもかかわらず、市場はいくつかの課題に直面しています。主なハードルのひとつは治療費で、多くの飼い主にとっては依然として高額であるため、この先進治療へのアクセスが制限される可能性があります。また、幹細胞製品の一貫性と品質を保証するために、規制当局による監視が必要です。さらに、幹細胞治療は様々な疾患の治療において有望視されているが、その可能性と限界を十分に理解するためには、まだ長期的な研究が必要です。このような課題にもかかわらず、この分野における成功例の増加や現在進行中の技術革新は、犬幹細胞治療の未来が明るいことを示唆しています。

犬幹細胞治療市場の成長を促進する要因とは？

犬幹細胞治療市場の成長は、獣医学の進歩、再生医療に対する認識の高まり、老犬や怪我をした犬に対する低侵襲な治療オプションに対する需要の高まりなど、いくつかの要因によってもたらされています。特に、ヘルスケアの向上によりペットの寿命が延びるにつれて、変形性関節症、股関節形成不全、靭帯損傷などの慢性疾患の有病率が増加していることが、この成長の主な要因です。犬の寿命が延びるにつれて、侵襲的な手術や長期的な投薬に頼らずにQOL（生活の質）を向上させる治療の必要性が高まっています。幹細胞治療は実行可能な解決策を提供し、運動能力を大幅に向上させ、痛みを軽減する再生効果をもたらします。さらに、凍結保存や同種幹細胞の使用など、幹細胞の処理と保存の進歩により、より幅広い獣医療現場が幹細胞療法を利用できるようになり、その普及をさらに後押ししています。ペットの飼い主が幹細胞治療の潜在的な効果について知識を深め、従来の治療に代わる治療法をペットに求めるようになったことも、消費者行動に大きな影響を及ぼしています。動物病院における幹細胞治療の普及と、バイオテクノロジー企業と動物病院との提携は、幹細胞治療の商業化と主流化を後押ししています。さらに、個々のペットのニーズに合わせて治療を行う個別化医療への関心が高まっており、幹細胞治療が様々な疾患の治療に対して高度にカスタマイズ可能なアプローチを提供することから、市場は引き続き拡大しています。バイオテクノロジーの継続的な進歩と消費者の関心の高まりにより、犬幹細胞治療市場は今後も持続的な成長が見込まれます。

調査対象企業の例（全47件）

  • Animal Cell Therapies, Inc
  • Aratana Therapeutics, Inc.
  • Cell Therapy Sciences
  • Magellan Stem Cells
  • MediVet Biologics, LLC
  • Okyanos
  • Regeneus Ltd.
  • Stem Cell Vet
  • Vetbiologics
  • VetMatrix

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10870

Global Canine Stem Cell Therapy Market to Reach US$253.8 Million by 2030

The global market for Canine Stem Cell Therapy estimated at US$200.1 Million in the year 2023, is expected to reach US$253.8 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Allogeneic Stem Cells, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$174.8 Million by the end of the analysis period. Growth in the Autologous Stem Cells segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$52.9 Million While China is Forecast to Grow at 3.3% CAGR

The Canine Stem Cell Therapy market in the U.S. is estimated at US$52.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2030 trailing a CAGR of 3.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Canine Stem Cell Therapy Market - Key Trends and Drivers Summarized

Why Is Canine Stem Cell Therapy Gaining Popularity in Veterinary Medicine?

Canine stem cell therapy has rapidly gained traction as a revolutionary treatment in veterinary medicine, offering hope for conditions that were once difficult to manage in dogs, particularly degenerative diseases, injuries, and immune disorders. Stem cells, especially those derived from a dog's own fat tissue (adipose-derived stem cells), have the unique ability to regenerate damaged tissues, reduce inflammation, and promote overall healing. This therapy is most commonly used to treat musculoskeletal conditions like osteoarthritis, hip dysplasia, and ligament injuries—ailments that cause significant pain and limited mobility in dogs, particularly as they age. Traditional treatments for these conditions, such as non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy, or even surgical interventions, can offer temporary relief but often come with side effects or the risk of complications. Stem cell therapy, by contrast, offers a less invasive solution with the potential for longer-lasting results. It works by harnessing the body’s natural healing processes, making it a more holistic approach to treating conditions that affect a dog’s mobility and quality of life. As more veterinarians and pet owners recognize its benefits, the demand for canine stem cell therapy has grown, reflecting a broader shift toward advanced regenerative therapies in animal care.

How Is Technology Advancing Canine Stem Cell Therapy?

The success and expanding reach of canine stem cell therapy are closely tied to rapid advancements in biotechnology and regenerative medicine. Over the past decade, significant progress has been made in how stem cells are processed and administered, improving the safety, efficacy, and convenience of these treatments for both veterinarians and pet owners. One major development is the refinement of methods for harvesting and processing adipose-derived stem cells, where stem cells can now be extracted, purified, and expanded in specialized laboratories with greater speed and precision. This allows for quicker treatment cycles and improved outcomes, as the quality and viability of the stem cells have a direct impact on their therapeutic potential. Additionally, the use of allogeneic stem cells, which are derived from donor animals, is an emerging trend, particularly for cases where it may not be feasible to collect stem cells from the patient. This approach broadens the availability of treatments, offering a solution even for dogs with underlying conditions that complicate autologous stem cell collection. Another significant advancement is in cryopreservation techniques, which allow harvested stem cells to be stored long-term and reused in future treatments without requiring repeated surgeries. These technological innovations, combined with the use of imaging technologies like MRI and ultrasound for precise targeting of stem cell injections, have made stem cell therapy not only more accessible but also more effective at addressing complex and chronic conditions.

What Trends and Challenges Are Shaping the Canine Stem Cell Therapy Market?

Several key trends are shaping the rapid growth and evolution of the canine stem cell therapy market, driven largely by the increasing demand for non-invasive, regenerative treatments for pets. As pet owners become more informed about advanced veterinary care options, there is a growing preference for therapies that can deliver better outcomes with fewer side effects compared to conventional treatments. This trend aligns with a broader movement in the pet care industry toward holistic and integrative treatments, where the focus is on promoting overall wellness and addressing the root causes of conditions rather than just managing symptoms. Moreover, the expanding research and clinical evidence supporting the efficacy of stem cell therapy in treating degenerative joint diseases, such as osteoarthritis, has bolstered its credibility among veterinarians, further encouraging its adoption. However, despite these positive trends, the market faces several challenges. One of the main hurdles is the cost of treatment, which remains high for many pet owners, potentially limiting access to this advanced therapy. There is also a need for more regulatory oversight to ensure the consistency and quality of stem cell products, as variations in how stem cells are processed can impact their safety and effectiveness. Moreover, while stem cell therapy has shown promise in treating a variety of conditions, long-term studies are still needed to fully understand its potential and limitations. Despite these challenges, the increasing number of success stories and ongoing innovations in the field suggest that the future of canine stem cell therapy is bright.

What Factors Are Propelling Growth in the Canine Stem Cell Therapy Market?

The growth in the canine stem cell therapy market is driven by several factors, including advancements in veterinary science, increased awareness of regenerative medicine, and the rising demand for minimally invasive treatment options for aging and injured dogs. A key driver of this growth is the increasing prevalence of chronic conditions such as osteoarthritis, hip dysplasia, and ligament injuries in dogs, particularly as pet lifespans increase due to improved healthcare. As dogs live longer, the need for treatments that can enhance their quality of life without relying on invasive surgery or long-term medications becomes more critical. Stem cell therapy provides a viable solution, offering regenerative benefits that can significantly improve mobility and reduce pain. Additionally, advancements in the processing and storage of stem cells, including cryopreservation and the use of allogeneic stem cells, have made the therapy more accessible to a wider range of veterinary practices, further driving its adoption. Consumer behavior also plays a significant role, as pet owners become more educated about the potential benefits of stem cell therapy and seek alternatives to traditional treatments for their pets. The increasing availability of stem cell therapy at veterinary clinics, coupled with partnerships between biotech companies and veterinary practices, is helping to commercialize the therapy and make it more mainstream. Furthermore, the rising interest in personalized veterinary care, where treatments are tailored to the specific needs of individual pets, continues to propel the market, as stem cell therapy offers a highly customizable approach to treating a wide range of conditions. With ongoing advancements in biotechnology and growing consumer interest, the canine stem cell therapy market is poised for sustained growth in the coming years.

Select Competitors (Total 47 Featured) -

  • Animal Cell Therapies, Inc
  • Aratana Therapeutics, Inc.
  • Cell Therapy Sciences
  • Magellan Stem Cells
  • MediVet Biologics, LLC
  • Okyanos
  • Regeneus Ltd.
  • Stem Cell Vet
  • Vetbiologics
  • VetMatrix

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Canine Stem Cell Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Canine Osteoarthritis Throws the Spotlight on Stem Cell Therapy as a Key Treatment Option
    • Here's How Advancements in Regenerative Medicine Drive Adoption of Canine Stem Cell Therapy
    • Growing Demand for Minimally Invasive Treatments Spurs Growth in Stem Cell Therapy for Pets
    • Increasing Pet Ownership and Spending on Pet Healthcare Expands Addressable Market Opportunity for Stem Cell Therapies
    • Here's the Story: Improved Stem Cell Isolation Techniques Propel Growth in Treatment Efficacy
    • Advances in Cryopreservation Technologies Generate New Opportunities for Repeat Stem Cell Treatments
    • Growing Interest in Alternative Therapies for Pain Management Propels Adoption of Stem Cell Treatments
    • Research on Stem Cell Applications for Immune and Neurological Disorders Expands Treatment Horizons
    • Increased Availability of Stem Cell Therapies in Specialty Veterinary Clinics Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Canine Stem Cell Therapy Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Autologous Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Veterinary Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Veterinary Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Veterinary Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • JAPAN
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • CHINA
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • EUROPE
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • FRANCE
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • GERMANY
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030

IV. COMPETITION